The maker of Tylenol is being sold to Kimberly-Clark in a $48.7 billion deal weeks after President Donald Trump and Health Secretary Robert F Kennedy Jr targeted the drug.
Kimberly-Clark’s purchase of drug maker Kenvue will create a massive consumer health goods company.